Cell Free DNA for the Diagnosis and Treatment in Early NSCLC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Home/Non-small Cell Lung Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Non-small Cell Lung Cancer trials

Trial locations(1 site)

South Korea

Samsung Medical Center, Seoul

Key details

Sponsor

Samsung Medical Center

Collaborators

Guardant Health, Inc.

Enrollment target

~700 participants

Started

August 2017

Primary completion

December 2021

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 90 Years

Last updated May 2021

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Cell Free DNA for the Diagnosis and Treatment in Early NSCLC — Stella